Mayo Clinic researchers develop first salivary gland regenerative biobank to combat chronic dry mouth

Yi Rong appointed editor-in-chief of Journal of Applied Clinical Medical Physics

Yi Rong was appointed editor-in-chief of the American Association Of Physicists In Medicine’s Journal of Applied Clinical Medical Physics by the AAPM board of directors.

August 01, 2025

Vol.51 No.30

In Brief

Henry Ford + MSU researchers granted $3M from NIH to study HPV-positive head-and-neck cancers

The National Institute of Dental and Craniofacial Research awarded a $3 million grant to researchers from Henry Ford Health + Michigan State University Health Sciences to study new treatments for patients who have head-and-neck cancer caused by HPV.

July 25, 2025

Vol.51 No.29

Clinical Roundup

Tagrisso + chemo improve OS in EGFR-mutated advanced lung cancer, phase III trial shows

Tagrisso (osimertinib) plus chemotherapy delivers a statistically significant and clinically meaningful survival benefit compared to Tagrisso monotherapy in the first-line treatment of patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer, according to results from the final overall survival analysis of the FLAURA2 phase III trial.

July 25, 2025

Vol.51 No.29

Clinical Roundup

Mayo Clinic researchers link CAR T-cell aging to cancer relapse

The aging process known as senescence is a mechanism involved in the failure of CAR T-cell therapy, according to a study by researchers at the Mayo Clinic.

July 18, 2025

Vol.51 No.28

Clinical Roundup

Sequences of cancer treatments affect patient outcomes and healthcare costs, UC Irvine-led study shows

Specific sequences of chemotherapy, targeted therapy, and immunotherapy yielded significantly different results, according to a study that utilized simulation models and real-world data to predict outcomes under different sequencing scenarios.

July 18, 2025

Vol.51 No.28

Clinical Roundup

Neoadjuvant ablative radiotherapy + chemo reduces risk of pancreatic cancer regrowth, stimulates immune system, cohort study finds

Adding targeted radiation to chemotherapy prior to surgery may offer better control of pancreatic tumors—potentially reducing the rate of recurrence after treatment, according to a cohort study from Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center.

July 11, 2025

Vol.51 No.27

Mayo Clinic researchers develop first salivary gland regenerative biobank to combat chronic dry mouth

YOU MAY BE INTERESTED IN

Yi Rong appointed editor-in-chief of Journal of Applied Clinical Medical Physics

Henry Ford + MSU researchers granted $3M from NIH to study HPV-positive head-and-neck cancers

Tagrisso + chemo improve OS in EGFR-mutated advanced lung cancer, phase III trial shows

Mayo Clinic researchers link CAR T-cell aging to cancer relapse

Sequences of cancer treatments affect patient outcomes and healthcare costs, UC Irvine-led study shows

Neoadjuvant ablative radiotherapy + chemo reduces risk of pancreatic cancer regrowth, stimulates immune system, cohort study finds

Renew today!

Subscriber content

Never miss an issue!

Login